Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease
- 25 July 2007
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (20) , 6565-6573
- https://doi.org/10.1016/j.bmc.2007.07.001
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- MHC class II proteins and disease: a structural perspectiveNature Reviews Immunology, 2006
- Structural Basis for Gluten Intolerance in Celiac SprueScience, 2002
- Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and InhibitorsAngewandte Chemie International Edition in English, 1998
- Altered Peptide Ligand–Induced Partial T Cell Activation: Molecular Mechanisms and Role in T Cell BiologyAnnual Review of Immunology, 1996
- Receptor-ligand interactions measured by an improved spun column chromatography technique A high efficiency and high throughput size separation methodBiochimica et Biophysica Acta (BBA) - General Subjects, 1995
- The Role of the Major Histocompatibility Complex in AutoimmunityClinical Immunology and Immunopathology, 1993
- Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide.The Journal of Experimental Medicine, 1993
- Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptorCell, 1992
- In vivo competition between self peptides and foreign antigens in T-cell activationNature, 1988
- A Molecular Basis for MHC Class II—Associated AutoimmunityScience, 1988